ARC Linkage - $370,000

A new molecule for the treatment of pulmonary lung fibrosis has been developed but there is no inhalation medicine capable of targeting the responsible cells. This project will develop an advanced inhalation technology capable of bypassing the lung surface so that we can target the fibrotic cells beneath.